Daniel Brims

Daniel Brims

Analyst-Equity chez
Lake Street Capital Markets LLC
Finance
Consumer Services
Health Technology

Profil

Dr. Daniel Brims is a Senior Research Analyst at Lake Street Capital Markets LLC.
He brings over 15 years of experience in the biotech sector.
Previously, Dr. Brims was Vice President of Healthcare Investment Banking at H.C.
Wainwright & Co. and spent eight years as a senior research analyst working on both the buy side at Wolfswood Partners and the sell side at Cantor Fitzgerald and Brean Capital.
Prior to working on Wall treet, he started his career as a scientist at Regeneron Pharmaceuticals, where he ran their recombinant E.
coli protein expression facility.
He earned a Ph.D.
in Chemistry from the University of Washington and a BS in Chemistry from the University of Wisconsin, Madison.

Postes actifs de Daniel Brims

SociétésPosteDébut
Analyst-Equity 01/12/2025

Anciens postes connus de Daniel Brims

SociétésPosteFin
Analyst-Equity 01/10/2015
Analyst-Equity 31/07/2014
Analyst-Equity 31/05/2013
Corporate Officer/Principal 31/03/2013
REGENERON PHARMACEUTICALS, INC. Corporate Officer/Principal 31/07/2011
Voir l'expérience en détail de Daniel Brims

Formation de Daniel Brims

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

79

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Finance

Finance

Consumer Services

Consumer Services

Finance

Finance

  1. Bourse
  2. Insiders
  3. Daniel Brims
🔇